Revocation
of
Statement of Principles
concerning
AORTIC ATHEROSCLEROTIC DISEASE
and
Determination
of
Statement of Principles
concerning
NON-ANEURYSMAL
AORTIC ATHEROSCLEROTIC DISEASE
ICD-9-CM CODES: 440.0, 444.0, 444.1
Veterans’ Entitlements Act 1986
1. The Repatriation Medical Authority under subsection 196B(3)
of the Veterans’ Entitlements Act 1986 (the Act):
(a) revokes Instrument No.90 of
1995 (Statement of Principles concerning aortic atherosclerotic disease); and
(b) determines in its place the
following Statement of Principles.
Kind of injury, disease
or death
2. (a) This Statement of Principles is about non-aneurysmal aortic atherosclerotic disease and death from
non-aneurysmal aortic atherosclerotic disease.
(b) For the purposes of this
Statement of Principles, “non-aneurysmal aortic atherosclerotic disease”
means the presence of atherosclerosis in the aorta, which causes either:
(i) a partial or complete
occlusion of the abdominal aorta with clinical manifestations of claudication
in the lower back, buttocks, hips, thighs, or calves, or reduced pulsation in
the femoral arteries, or pallor and coldness of the lower extremities; or
(ii) a penetrating ulcer of the aorta with clinical
manifestations of sudden onset of chest or back pain, or haemodynamic
instability, or intramural haematoma, or false aortic aneurysm, or aortic
rupture,
attracting ICD-9-CM codes 440.0, 444.0 or 444.1.
Basis for determining the
factors
3. On the sound medical-scientific evidence available, the
Repatriation Medical Authority is of the view that it is more probable than not
that non-aneurysmal aortic atherosclerotic disease and death from
non-aneurysmal aortic atherosclerotic disease can be related to relevant
service rendered by veterans or members of the Forces.
Factors that must be
related to service
4. Subject to clause 6, at least one of the factors set out in
clause 5 must be related to any relevant service rendered by the person.
Factors
5. The factors that must exist before it can be said that, on the
balance of probabilities, non-aneurysmal aortic atherosclerotic disease
or death from non-aneurysmal aortic atherosclerotic disease is connected
with the circumstances of a person’s relevant service are:
(a) smoking at least five
cigarettes per day or the equivalent thereof in other tobacco products, for at
least six years before the clinical onset of non-aneurysmal aortic
atherosclerotic disease; or
(b) suffering from hypertension
before the clinical onset of non-aneurysmal aortic atherosclerotic disease; or
(c) suffering from dyslipidaemia
before the clinical onset of non-aneurysmal aortic atherosclerotic disease; or
(d) suffering from diabetes
mellitus before the clinical onset of non-aneurysmal aortic atherosclerotic
disease; or
(e) for aortic occlusive disease
only, undergoing a course of therapeutic radiation to the region of the
affected aorta before the clinical onset of non-aneurysmal aortic
atherosclerotic disease; or
(f) smoking at least five
cigarettes per day or the equivalent thereof in other tobacco products, for at
least six years before the clinical worsening of non-aneurysmal aortic
atherosclerotic disease; or
(g) suffering from hypertension,
which developed before the clinical worsening of non-aneurysmal aortic
atherosclerotic disease; or
(h) suffering from dyslipidaemia,
which developed before the clinical worsening of non-aneurysmal aortic
atherosclerotic disease; or
(j) suffering from diabetes
mellitus, which developed before the clinical worsening of non-aneurysmal
aortic atherosclerotic disease; or
(k) for aortic occlusive disease
only, undergoing a course of therapeutic radiation to the region of the
affected aorta before the clinical worsening of non-aneurysmal aortic
atherosclerotic disease; or
(m) inability to obtain
appropriate clinical management for non-aneurysmal aortic atherosclerotic
disease.
Factors that apply only
to material contribution or aggravation
6. Paragraphs 5(f) to 5(m) apply only to material
contribution to, or aggravation of, non-aneurysmal aortic atherosclerotic disease
where the person’s non-aneurysmal aortic atherosclerotic disease was suffered
or contracted before or during (but not arising out of) the person’s relevant
service; paragraph 8(1)(e), 9(1)(e) or 70(5)(d) of the Act refers.
Inclusion of Statements of Principles
7. In this Statement of Principles if a relevant
factor applies and that factor includes an injury or disease in respect of
which there is a Statement of Principles then the factors in that last
mentioned Statement of Principles apply in accordance with the terms of that
Statement of Principles.
Other definitions
8. For the purposes of this Statement of
Principles:
“a course of therapeutic radiation” means one or more fractions (treatment portions) of
ionising radiation administered with the aim of achieving palliation or cure
with gamma rays, x-rays, alpha particles or beta particles;
“cigarettes per day or the equivalent thereof, in
other tobacco products” means either
cigarettes, pipe tobacco or cigars, alone or in any combination where one
tailor made cigarette approximates one gram of tobacco; or one gram of cigar,
pipe or other smoking tobacco by weight;
“death from non-aneurysmal aortic atherosclerotic
disease” in relation to a person
includes death from a terminal event or condition that was contributed to by
the person’s non-aneurysmal aortic atherosclerotic disease;
“dyslipidaemia”
generally means evidence of a persistently abnormal lipid profile after the
accurate evaluation of serum lipids following a 12 hour overnight fast, and estimated
on a minimum of two occasions as a:
(a) total serum cholesterol level
greater than or equal to 5.5 mmol/L; or
(b) fasting serum triglyceride
level greater than or equal to 2.0 mmol/L together with high density
lipoprotein cholesterol level less than 0.9 mmol/L;
Note: the
source for this definition is: NHF Australia, Guide to Plasma
Lipids for Doctors;
Current
Therapeutics, Vol 33 Supplement 1, 1992.
“hypertension” means elevated baseline blood pressure, evidenced by:
(a) a usual blood pressure
reading where the systolic reading is greater than or equal to 140 mmHg
and/ or where the diastolic reading is greater than or equal to 90 mmHg; or
(b) administration of antihypertensive
therapy;
“ICD-9-CM code” means a number assigned to a particular kind of injury or disease in
the Australian Version of The International Classification of Diseases, 9th
revision, Clinical Modification (ICD-9-CM), effective date of 1 July 1996,
copyrighted by the National Coding Centre, Faculty of Health Sciences,
University of Sydney, NSW, and having ISBN 0 642 24447 2;
“relevant service” means:
(a) eligible war service (other
than operational service); or
(b) defence service (other than
hazardous service);
“terminal event” means the proximate or ultimate cause of death and
includes:
a) pneumonia;
b) respiratory failure;
c) cardiac arrest;
d) circulatory failure; or
e) cessation of brain function.
Application
9. This Instrument applies to all matters to which section 120B
of the Act applies.
Notes to Statement of Principles concerning
non-aneurysmal aortic atherosclerotic disease (Instrument No. 69 of 1998)
The Statement of Principles concerning non-aneurysmal aortic
atherosclerotic disease (Instrument No. 69 of 1998) in force under section
196B(3) of the Veterans’ Entitlements Act 1986, as shown in this
compilation is amended as indicated in the Tables below.
Table
of Instruments
|
Title
|
Date of notification
in Gazette or FRLI registration
|
Date of
commencement
|
Application, saving or
transitional provisions
|
|
Statement
of Principles concerning non-aneurysmal aortic atherosclerotic disease
(Instrument No. 69 of 1998)
|
21 October 1998
(see Gazette 1998, No. GN42)
|
21 October 1998
|
|
|
Amendment
of Statement of Principles concerning non-aneurysmal aortic atherosclerotic
disease (Instrument No. 27 of 2002)
|
16 January 2002
(see Gazette 2002, No. GN2)
|
16 January 2002
|
|
Table of Amendments
|
ad. = added or inserted am. = amended
rep. = repealed rs. = repealed and substituted
|
|
Provision affected
|
How affected
|
|
Paragraph 8 – ‘diabetes mellitus’.............................
|
rep. Instrument No.27 of 2002
|